DRTS · NASDAQ
Alpha Tau Medical (DRTS) Stock Price & Fundamentals
Alpha Tau Medical (DRTS) closed at $673.63 on Oct 9, 2026, down 1.59% from the previous close of $684.53.
Share price, past year
1Y +15.45%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $673.63 |
| Sep 30, 2026 | $678.25 |
| Aug 31, 2026 | $658.39 |
| Jul 31, 2026 | $617.72 |
| Jun 30, 2026 | $605.38 |
| May 29, 2026 | $593.88 |
| Apr 30, 2026 | $595.87 |
| Mar 31, 2026 | $618.38 |
| Feb 27, 2026 | $582.20 |
| Jan 30, 2026 | $586.39 |
| Dec 31, 2025 | $571.51 |
| Nov 28, 2025 | $587.01 |
| Oct 31, 2025 | $577.76 |
Key statistics
- Market cap
- $59.29B
- Shares outstanding
- 88M
- 52-week range
- $559.60 – $691.79
Alpha Tau Medical's market cap is $59.29B, based on a share price of $673.63 and 88M shares outstanding as of Dec 31, 2025.
Financials
Alpha Tau Medical's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.
Alpha Tau Medical reported a net loss of $42.63M in fiscal 2025.
Company profile
- Name
- Alpha Tau Medical Ltd.
- Ticker
- DRTS
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Kiryat Hamada 5, Jerusalem, L3 9777605
- Incorporated in
- L3
- Fiscal year ends
- December
- SEC CIK
- 0001871321
Frequently asked questions
What is Alpha Tau Medical's stock price?
Alpha Tau Medical (DRTS) closed at $673.63 on Oct 9, 2026, down 1.59% from the previous close of $684.53.
What is Alpha Tau Medical's market cap?
Alpha Tau Medical's market cap is $59.29B, based on a share price of $673.63 and 88M shares outstanding as of Dec 31, 2025.
Sources and methodology
Fundamentals come from Alpha Tau Medical Ltd.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures